| (en millions d’euros) | 2024 | 2023 |
|---|---|---|
| Non-current income and (expenses) | Non-current income and (expenses) 2024 14 |
Non-current income and (expenses) 2023 (206) |
| Capital gains (losses) on disposal of assets | Capital gains (losses) on disposal of assets 2024 1 |
Capital gains (losses) on disposal of assets 2023 4 |
| Total non-current income and (expenses) | Total non-current income and (expenses) 2024 15 |
Total non-current income and (expenses) 2023 (202) |
In 2024, other non-current income and expenses mainly correspond to income of euro 14 million generated by the contribution of the exclusive right to use Citrus and Epsilon technologies to Unlimitail (see Note 15).
In 2023, other non-current income and expenses corresponded mainly to the cost of the settlement reached between the attorneys general of the 50 US States, the District of Columbia and certain US territories concerning the work carried out by the former advertising agency, Rosetta (merged with Publicis Health LLC), on behalf of opioid manufacturers. Under this settlement, the expense of euro 203 million/USD 220 million broke down as follows: USD (343) million to the States, USD (7) million to costs of the attorneys general for the costs of the investigation and other ancillary costs, offset by an insurance reimbursement of USD 130 million/euro 120 million (see also Note 22).
| (en millions d’euros) | 2024 | 2023 |
|---|---|---|
| Interest expenses on loans and bank overdrafts | Interest expenses on loans and bank overdrafts 2024 (122) |
Interest expenses on loans and bank overdrafts 2023 (120) |
| Income from cash and cash equivalents | Income from cash and cash equivalents 2024 135 |
Income from cash and cash equivalents 2023 152 |
| Income (expenses) on derivatives | Income (expenses) on derivatives 2024 39 |
Income (expenses) on derivatives 2023 46 |
| Financial debt expenses | Financial debt expenses 2024 (122) |
Financial debt expenses 2023 (120) |
| Financial debt income | Financial debt income 2024 174 |
Financial debt income 2023 198 |
| Cost of net financial debt | Cost of net financial debt 2024 52 |
Cost of net financial debt 2023 78 |
| Interest expense on lease liabilities | Interest expense on lease liabilities 2024 (84) |
Interest expense on lease liabilities 2023 (79) |
| Change in fair value of financial assets | Change in fair value of financial assets 2024 10 |
Change in fair value of financial assets 2023 (1) |
| Foreign exchange gains (losses) and change in the fair value of derivatives | Foreign exchange gains (losses) and change in the fair value of derivatives 2024 1 |
Foreign exchange gains (losses) and change in the fair value of derivatives 2023 (7) |
| Other | Other 2024 (8) |
Other 2023 (12) |
| Other financial income and expenses | Other financial income and expenses 2024 (81) |
Other financial income and expenses 2023 (99) |
| Financial result excluding revaluation of earn-out commitments | Financial result excluding revaluation of earn-out commitments 2024 (29) |
Financial result excluding revaluation of earn-out commitments 2023 (21) |
| Revaluation of earn-out commitments | Revaluation of earn-out commitments 2024 35 |
Revaluation of earn-out commitments 2023 12 |
| Financial result | Financial result 2024 6 |
Financial result 2023 (9) |
